ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
124.305,57
-0,34%
S&P 500
5.304,72
0,70%
US Dollar vs BRL
5,1672
0,56%
Bitcoin
69.313,72
0,07%
Brent Oil
81,965
0,00%
Registration Strip Icon for pro Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Biofrontera Inc (BFRI)

  7. Biofrontera Inc (BFRI) Notícias

BFRI

Biofrontera (BFRI)

Biofrontera Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:BFRI
DataHoraFonteTítuloCódigoCompanhia
08/03/202419:14Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:BFRIBiofrontera Inc
05/03/202419:20Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:BFRIBiofrontera Inc
23/02/202411:26Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BFRIBiofrontera Inc
20/02/202409:55Edgar (US Regulatory)Form RW - Registration Withdrawal RequestNASDAQ:BFRIBiofrontera Inc
09/01/202419:01Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:BFRIBiofrontera Inc
17/11/202308:02Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:BFRIBiofrontera Inc
09/11/202319:23Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:BFRIBiofrontera Inc
01/11/202318:09Edgar (US Regulatory)Form 424B4 - Prospectus [Rule 424(b)(4)]NASDAQ:BFRIBiofrontera Inc
31/10/202301:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:BFRIBiofrontera Inc
04/10/202322:48Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:BFRIBiofrontera Inc
22/08/202317:30Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:BFRIBiofrontera Inc
20/06/202317:31Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:BFRIBiofrontera Inc
28/04/202310:12Edgar (US Regulatory)Amended Securities Registration (section 12(b)) (8-a12b/a)NASDAQ:BFRIBiofrontera Inc
11/04/202317:44Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:BFRIBiofrontera Inc
16/12/202210:30GlobeNewswire Inc.Biofrontera Inc. Announces Voting Results from 2022 Annual Meeting of StockholdersNASDAQ:BFRIBiofrontera Inc
08/12/202218:06Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:BFRIBiofrontera Inc
30/11/202216:08GlobeNewswire Inc.Biofrontera Inc. to Participate in Benchmark’s 11th Annual Discovery One-on-One Investor ConferenceNASDAQ:BFRIBiofrontera Inc
28/11/202213:05GlobeNewswire Inc.BIOFRONTERA INC. TO PARTICIPATE IN RENMARK’S VIRTUAL NON-DEAL ROADSHOW SERIES ON WEDNESDAY, NOVEMBER 30, MONDAY, DECEMBER 5, FRIDAY, DECEMBER 9, AND MONDAY, DECEMBER 19 2022NASDAQ:BFRIBiofrontera Inc
21/11/202210:48GlobeNewswire Inc.Biofrontera to Launch Phase 3 Clinical Study Evaluating Ameluz®-PDT for the Treatment of Actinic Keratosis on the Extremities, Neck and TrunkNASDAQ:BFRIBiofrontera Inc
15/11/202219:29Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:BFRIBiofrontera Inc
14/11/202210:59Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:BFRIBiofrontera Inc
14/11/202210:45GlobeNewswire Inc.Biofrontera Inc. Reports Third Quarter 2022 Financial Results and Provides a Business UpdateNASDAQ:BFRIBiofrontera Inc
14/11/202208:05Edgar (US Regulatory)Revised Proxy Soliciting Materials (definitive) (defr14a)NASDAQ:BFRIBiofrontera Inc
10/11/202213:52GlobeNewswire Inc.Biofrontera Inc. to Report Third Quarter Financial Results on November 14, 2022NASDAQ:BFRIBiofrontera Inc
08/11/202218:45GlobeNewswire Inc.Biofrontera Inc. Fully Exercises Recently Acquired Options to Purchase Shares of Biofrontera AGNASDAQ:BFRIBiofrontera Inc
08/11/202208:04Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:BFRIBiofrontera Inc
04/11/202217:06Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:BFRIBiofrontera Inc
03/11/202207:06Edgar (US Regulatory)Securities Registration Statement (s-1)NASDAQ:BFRIBiofrontera Inc
31/10/202209:55GlobeNewswire Inc.Biofrontera Inc. Enters into Agreements to Purchase Options of Biofrontera AGNASDAQ:BFRIBiofrontera Inc
24/10/202208:45GlobeNewswire Inc.Biofrontera Inc. Names Fred Leffler as Chief Financial OfficerNASDAQ:BFRIBiofrontera Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:BFRI

Seu Histórico Recente

NASDAQ
BOKF
BOK Financial
AMEX
ERSX
ERShares NextGen Entrepr...
LSE
BWRA
Bristol Wtr.8t%
AMEX
FFVX
TSXV
VQS
VIQ Solutions
LSE
MAVC
EU
RAUWC
Rgion AuvergneRhne Rara0...
COIN
SOULCUSD
CSE
LFNT
LFNT Resources
LSE
MXX
USOTC
CPNNF
Central Pattana Public (PK)
BOV
BLPA39
Global X Funds
COIN
YOVIUSD
USOTC
RBRXF
Rhino Biotech (CE)
NASDAQ
FTBSX
Franklin Moderate Alloca...
GATE
VETETH
VeChain Token
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados